Orphazyme A/S Profit Margin

Orphazyme A/S's profit margin stands at -Infinity% as of June 2024. That compares with -24.87% in the prior-year period — down Infinity% year over year. That is below the Healthcare sector average of 15.58%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Orphazyme A/S reported -Infinity% in profit margin versus -24.87% a year earlier — a Infinity% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Orphazyme A/S sits lower the Healthcare benchmark (15.58%) with a profit margin of -Infinity%. That is roughly Infinity% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -Infinity% for Orphazyme A/S means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Orphazyme A/S's profit margin evolved across reporting periods, while the comparison chart places ORPHY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.